Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pregnancy Test Tells When Conception Occurred

By LabMedica International staff writers
Posted on 29 Sep 2008
A one-step rapid pregnancy test also indicates an approximate date of conception.

The test is very simple and accurate. More...
Urine is applied to an absorbent sampler activating the test, which automatically calibrates itself. A "Wait” symbol on the liquid crystal display (LCD) display screen indicates the test is working. Within three minutes, an easy to read result is displayed. If the test is positive, "Pregnant” will be indicated in words on the display along with the Conception Indicator result. This is displayed as an estimate of how many weeks have occurred since conception: 1-2 weeks, 2-3 weeks or 3+ weeks.

Once a fertilized egg implants in the uterus wall, a woman's body produces the pregnancy hormone, human chorionic gonadotropin (hCG). This rapidly increases during the early weeks of pregnancy and is present in urine. It is this hormone that pregnancy tests detect when confirming a positive result. Clearblue (Waltham, MA, USA) launched the Clearblue digital pregnancy test with Conception Indicator--the only pregnancy test that is so advanced it is capable of telling a woman both if she is pregnant, and provide an indication when she might have conceived.

In laboratory tests, Clearblue digital pregnancy test is more than 99% accurate in detecting pregnancy, when used from the day the period is due. The Conception Indicator result is 92% accurate at indicating when a woman conceived, and when using the first urine of the day. As with the original Clearblue digital pregnancy test, the Conception Indicator is a one-step rapid test designed to be used once before disposal.

Clearblue launched the new test following extensive clinical studies to pinpoint the different levels of hCG required to estimate when conception occurred. Dr. Jayne Ellis, director of new product development at Clearblue commented, "The Conception Indicator is something we have been researching for a number of years, and the final product is unique. We are excited to be able to offer women more valuable information about their pregnancy as soon as the "pregnant” result is confirmed.”

Related Links:
Clearblue



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.